Maternal pertussis vaccination boosts infant protection up to eight months

In a large-scale Australian study, maternal vaccination during pregnancy significantly increased pertussis resistance in infants up to eight months. While it slightly reduced the effectiveness of infants’ routine vaccinations, it did not increase infection risk.

New Firearm Injury Numbers; Another Indication for Semaglutide?

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

August 4, 2024

FDA approves Citius Pharma’s non-Hodgkin lymphoma drug Lymphir

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 9, 2024

Defense Official Had Havana Syndrome Symptoms at NATO Summit, Pentagon Confirms

WASHINGTON (AP) — A senior Department of Defense (DOD) official who attended last year’s NATO summit in Vilnius, Lithuania, had symptoms similar to those reported

April 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.